Palmar plantar erythrodysesthesia causes: Difference between revisions
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
==Causes== | ==Causes== | ||
Commonly associated chemotherapeutic agents are listed below: | Commonly associated chemotherapeutic agents are listed below: | ||
* Most frequently associated with Doxorubicin (Pegylated liposomal Doxorubicin), 5-Flurouracil, and Cytarabine . | * Most frequently associated with Doxorubicin (Pegylated liposomal Doxorubicin), 5-Flurouracil, and Cytarabine<ref name="pmid17350337">{{cite journal| author=Webster-Gandy JD, How C, Harrold K| title=Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre. | journal=Eur J Oncol Nurs | year= 2007 | volume= 11 | issue= 3 | pages= 238-46 | pmid=17350337 | doi=10.1016/j.ejon.2006.10.004 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17350337 }}</ref>. | ||
* Methotrexate - even low dose used to treat ALL | * Methotrexate - even low dose used to treat ALL<ref name="pmid1441532">{{cite journal| author=Wysocki M, Nowaczyk-Michalak A, Pilecki O, Kurylak A, Balcar-Boroń A, Trybuś L| title=[Burgdorf's reaction (painful acral erythema) in patients with acute lymphoblastic leukemia following medium-dose methotrexate therapy]. | journal=Wiad Lek | year= 1992 | volume= 45 | issue= 11-12 | pages= 462-4 | pmid=1441532 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1441532 }}</ref> | ||
* Mitotane | * Mitotane | ||
* PLD, Docetaxel, Capecitabine, vinorelbine, gemcitabine and Sorafenib | * PLD, Docetaxel, Capecitabine, vinorelbine, gemcitabine and Sorafenib | ||
Revision as of 14:43, 7 October 2018
|
Palmar plantar erythrodysesthesia Microchapters |
|
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Palmar plantar erythrodysesthesia causes On the Web |
|
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia causes |
|
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
|
Risk calculators and risk factors for Palmar plantar erythrodysesthesia causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Several different Chemotherapeutic agents have been associated with acral erythema[1]
Causes
Commonly associated chemotherapeutic agents are listed below:
- Most frequently associated with Doxorubicin (Pegylated liposomal Doxorubicin), 5-Flurouracil, and Cytarabine[2].
- Methotrexate - even low dose used to treat ALL[3]
- Mitotane
- PLD, Docetaxel, Capecitabine, vinorelbine, gemcitabine and Sorafenib
Genetics
No genetic association has been found as of yet as the data on this condition is limited.
References
- ↑ Baack BR, Burgdorf WH (1991). "Chemotherapy-induced acral erythema". J Am Acad Dermatol. 24 (3): 457–61. PMID 2061446.
- ↑ Webster-Gandy JD, How C, Harrold K (2007). "Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre". Eur J Oncol Nurs. 11 (3): 238–46. doi:10.1016/j.ejon.2006.10.004. PMID 17350337.
- ↑ Wysocki M, Nowaczyk-Michalak A, Pilecki O, Kurylak A, Balcar-Boroń A, Trybuś L (1992). "[Burgdorf's reaction (painful acral erythema) in patients with acute lymphoblastic leukemia following medium-dose methotrexate therapy]". Wiad Lek. 45 (11–12): 462–4. PMID 1441532.